Newcells bags another £1.2m for lab models that replace animal testing

Quick Summary:

Alex Buchan of Northstar Ventures added: “We have been closely involved with Newcells since its founding and are proud of their significant progress to date.

Research has found that around 90% of drugs shown to be safe and effective in animals do not work as planned in humans, which is one reason for the high failure rate in drug development.

The use of advanced 3D models has attracted increasing interest after the US Food and Drug Administration (FDA) changed its rules two years ago, removing the requirement for new drugs to be tested on animals.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Jonathan Symcox

Category: InvestingBusiness

Markets: United Kingdom

Topics: MedTech Investment

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-06 @ 05:40:27 (2 weeks ago)

News Timezone: GMT +8:00

News Source URL: businesscloud.co.uk

Language: English

Article Length: 615 words

Reading Time: 4 minutes read

Sentences: 21 lines

Sentence Length: 30 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © BusinessCloud

News ID: 24314377

View Article Analysis

About BusinessCloud

Main Topics: InvestingBusiness

Official Website: businesscloud.co.uk

Year Established: 2016

Headquarters: United Kingdom

News Last Updated: 3 days ago

Coverage Areas: United Kingdom

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #61

Publisher Details

Frequently Asked Questions